GSK Files Lawsuit Against Pfizer and BioNTech for Alleged COVID-19 Vaccine Patent Violation

1. British pharmaceutical giant GlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech, alleging that their COVID-19 vaccine infringes on GSK's intellectual property rights.
2. The lawsuit claims that Pfizer and BioNTech's vaccine, Comirnaty, uses technology patented by GSK, specifically related to the use of mRNA technology in vaccines.
3. GSK is seeking damages and a court order to stop Pfizer and BioNTech from using the disputed technology without authorization.
4. Pfizer and BioNTech have not yet publicly commented on the lawsuit.
5. This is one of the first major patent disputes related to COVID-19 vaccines, which have been developed and distributed at an unprecedented pace during the pandemic.
6. The outcome of this lawsuit could have significant implications for the future of vaccine development and intellectual property rights in the pharmaceutical industry.